Tomas D. Bertmark
Director/Miembro de la Junta en CanImGuide Therapeutics AB .
Cargos activos de Tomas D. Bertmark
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Miembro de la Junta | - | - |
| Corporate Officer/Principal | - | - |
Historial de carrera de Tomas D. Bertmark
Estadísticas
Internacional
| Suecia | 2 |
Operativa
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Tomas D. Bertmark
- Experiencia
